These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Vasoactive and inotropic drugs in acute heart failure]. Ruiz-Laiglesia FJ; Camafort-Babkowski M Med Clin (Barc); 2014 Mar; 142 Suppl 1():49-54. PubMed ID: 24930084 [TBL] [Abstract][Full Text] [Related]
3. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations. Heywood JT; Khan TA Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950 [TBL] [Abstract][Full Text] [Related]
4. Role of nonglycosidic inotropic agents: indications, ethics, and limitations. Chatterjee K; De Marco T Med Clin North Am; 2003 Mar; 87(2):391-418. PubMed ID: 12693731 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pharmacological therapy in children--a review. Part 1: Use of inotropic agents. Chan KY; Yip WC; Tay JS J Singapore Paediatr Soc; 1988; 30(3-4):90-9. PubMed ID: 3063886 [No Abstract] [Full Text] [Related]
6. Inotropic and vasoactive drugs for management of the critically ill. McGrath RB Acute Care; 1988-1989; 14-15():293-312. PubMed ID: 3155034 [TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacology of inodilators. Dei Cas L; Metra M; Visioli O J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents. Simonton CA West J Med; 1985 Feb; 142(2):235-44. PubMed ID: 4013252 [No Abstract] [Full Text] [Related]
9. Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure. Elkayam U; Tasissa G; Binanay C; Stevenson LW; Gheorghiade M; Warnica JW; Young JB; Rayburn BK; Rogers JG; DeMarco T; Leier CV Am Heart J; 2007 Jan; 153(1):98-104. PubMed ID: 17174645 [TBL] [Abstract][Full Text] [Related]
10. Vintners and vasodilators: are French red wines more cardioprotective? Vogel RA J Am Coll Cardiol; 2003 Feb; 41(3):479-81. PubMed ID: 12575979 [No Abstract] [Full Text] [Related]
11. [Physiological bases and therapeutic uses of inodilator drugs]. Costa R; De Marino V; Marino A Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377 [TBL] [Abstract][Full Text] [Related]
12. [Rational use of inotropic sympathomimetic amines in resuscitation]. Richard C; Berdeaux A Rev Prat; 1985 Jun; 35(35):2123-30. PubMed ID: 4048795 [No Abstract] [Full Text] [Related]
13. Making a choice of inotropes and vasodilators in clinical situations. Hug CC J Card Surg; 1990 Sep; 5(3 Suppl):272-7. PubMed ID: 2133856 [TBL] [Abstract][Full Text] [Related]
14. [Inotropic agents and/or vasodilators in the treatment of left ventricular failure]. Gourgon R; Aumont MC; Merillon JP Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):491-7. PubMed ID: 7171220 [No Abstract] [Full Text] [Related]
15. Sympathomimetics in heart failure. Drug Ther Bull; 1982 Oct; 20(20):77-9. PubMed ID: 7140532 [No Abstract] [Full Text] [Related]
16. [The pharmacology of drugs used for the treatment of cardiovascular disorders]. Klaus W Klin Anasthesiol Intensivther; 1976 Apr; (11):106-22. PubMed ID: 11364 [No Abstract] [Full Text] [Related]
18. Therapeutic approach to the failing heart. Green TP Pediatr Ann; 1985 Apr; 14(4):304, 307-8, 310-11. PubMed ID: 4011330 [TBL] [Abstract][Full Text] [Related]
19. [Choice of drugs in the treatment of intraoperative right ventricular dysfunction in heart surgery patients]. Meshcheriakov AV; Sandrikov VA; IavorovskiÄ AG; Flerov EV; Iumatov AE; Kovalevskaia OA Anesteziol Reanimatol; 1997; (5):19-23. PubMed ID: 9432886 [No Abstract] [Full Text] [Related]
20. Treatment of circulatory shock. Use of sympathomimetic and related vasoactive agents. Weil MH; Shubin H; Carlson R JAMA; 1975 Mar; 231(12):1280-6. PubMed ID: 235029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]